Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
05.08. | Vertex is smarting from a pain portfolio setback | ||
05.08. | Noom expands its GLP-1 range with 'microdose' package | ||
05.08. | Gates Foundation puts $2.5bn into 'ignored' women's health | ||
05.08. | NICE calls for better care after weight-loss therapy ends | ||
05.08. | Gedeon Richter brings HRT option back to the UK market | ||
04.08. | Top medical groups barred from CDC vaccine workgroups | ||
04.08. | UK starts 'world-first' gonorrhoea vaccination push | ||
04.08. | EVERSANA unveils industry's 'first AI marketing agency' | ||
04.08. | After phase 3 hit, Spine seeks path forward for pain drug | ||
04.08. | Sanofi grabs Chinese rights to Arrowhead rare disease drug | ||
01.08. | NHS broadens access to haemophilia A drug Hemlibra | ||
01.08. | ChatGPT can cut review times for clinical trial eligibility | ||
01.08. | Tech giants back unified health data-sharing platform in US | ||
31.07. | Trump gives pharma ultimatum on most favoured nation pricing | ||
31.07. | Moderna cuts staff amid operating 'uncertainty' | ||
31.07. | Lilly trumpets heart health data with Mounjaro | ||
31.07. | Google wearable AI can 'learn the language of our bodies' | ||
31.07. | Is AbbVie planning an epic Gilgamesh takeover? | ||
31.07. | Tidmarsh to stand in for Prasad's role at CBER | ||
30.07. | NICE CEO to step down by year-end | ||
30.07. | AbbVie files to move Venclexta combo into the CLL front line | ||
30.07. | AI picks up interval breast cancers missed by scans | ||
30.07. | GSK suffers a setback with its TIM-3 programme | ||
30.07. | White House retreats from block on NIH research funding | ||
30.07. | Vinay Prasad abruptly departs from the FDA |